University of Michigan
Michael Karsy
This research is studying a device already approved by the Food and Drug Administration (FDA) to treat wound closures. Researchers are studying a large group of people to continue to learn information about the safety of the STRATAFIX suture and how people's bodies react to using it over a long period of time. This research will provide additional information about using STRATAFIX sutures to close surgical wounds.
Wound Closure
Brain Tumor Adult
Spine
Neurovascular
Hemorrhagic Stroke, Intracerebral
Traumatic Brain Injury
STRATAFIX PDS and Monocryl suture
PHASE4
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 160 participants |
| Masking : | NONE |
| Primary Purpose : | TREATMENT |
| Official Title : | Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures |
| Actual Study Start Date : | 2025-11-01 |
| Estimated Primary Completion Date : | 2026-06-30 |
| Estimated Study Completion Date : | 2026-12-31 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
University of Michigan Health Sparrow
Lansing, road cancer, United States, 48912